0001209191-21-019666.txt : 20210310 0001209191-21-019666.hdr.sgml : 20210310 20210310200111 ACCESSION NUMBER: 0001209191-21-019666 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210228 FILED AS OF DATE: 20210310 DATE AS OF CHANGE: 20210310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rodino-Klapac Louise CENTRAL INDEX KEY: 0001836218 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 21731453 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: STE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4/A 1 doc4a.xml FORM 4/A SUBMISSION X0306 4/A 2021-02-28 2021-03-05 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001836218 Rodino-Klapac Louise 215 FIRST STREET CAMBRIDGE MA 0 1 0 0 Chief Scientific Officer Common Stock 2021-02-28 4 F 0 565 86.97 D 6604 D Common Stock 2021-03-03 4 A 0 15000 0.00 A 21780 D Shares were withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units granted on February 28, 2020. On March 5, 2021, the Form 4 filed for the reporting person overstated the number of shares held by the reporting person. This amended form corrects such error by reporting the number of shares withheld by the Company to satisfy tax withholding obligations related to vesting of restricted stock units on February 28, 2021 and by reporting the corrected total amount of securities directly owned by the reporting person following a grant of restricted stock units on March 3, 2021. The amount of securities directly owned by the reporting person includes 176 shares of common stock purchased under the Company's Amended and Restated 2013 Employee Stock Purchase Plan on February 28, 2021. /s/ Ryan Brown, as Attorney-in-Fact for Louise Rodino-Klapac 2021-03-10